Amy W. Schulman
At a glance: Amy W. Schulman is Director at Alnylam Pharmaceuticals (ALNY). Their latest SEC Form 4, filed Nov 12, 2026, reported a purchase of $300K. On file: 1 purchase line ($300K) and 1 sale line ($7K).
Disclosed holdings: about $3.8M of ALNY stock: 25,959 shares reported on their latest Form 4 (filed Nov 12, 2026), valued at the Nov 20, 2026 close of $147.97. This counts only ALNY shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Alnylam Pharmaceuticals, Inc. (ALNY); Director at Elevance Health, Inc. (ELV)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Amy W. Schulman's InsiderPrint
5 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.
Reading this print: Mostly buys, trading about once a year, typically $20K a trade; often buys after the stock has fallen 15% or more.
- Bump outward: a purchase (4)
- Dent inward: a sale (1)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Paul BisaroDirector · MYGN · 98% match
- Katharine WeymouthDirector · RSG · 97% matchTheir buys since 2021: 3 of 4 beat the S&P 500
- Nachum ShamirDirector · MDWD · 97% match
- Steven D. RubinDirector · ENTX · 97% match
- Vickie L. CappsDirector · OFIX · 97% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 12SEC | ALNYAlnylam Pharmaceuticals, Inc.First buy | Buy | 1,91025,959 held (+8%) | $156.82 | $300K | -5.6% |
| Mar 23SEC | ELVElevance Health, Inc. | Sell | 26218 held (−11%) | $287.50 | $7K | +36.0% |
- Buy
Director Amy W Schulman bought $300K of ALNY at $156.82 — first open-market purchase in our records.
Follow Amy W. Schulman
Get one email when Amy W. Schulman files a new purchase or sale. Free.
At most one email a day about Amy W. Schulman, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.